Vestland Pharma secures investment for novel salmon lice treatment

Norwegian biotech firm Vestland Pharma has secured NOK 12 million in funding from venture capital group Sarsia and seafood giant Coast Seafood to fast-track the launch of its new natural salmon lice treatment.